Production (Stage)
Cognition Therapeutics, Inc.
CGTX
$0.322
$0.02377.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.33% | 3.67% | -47.24% | -48.98% | -48.27% |
| Total Depreciation and Amortization | -22.41% | 7.58% | 7.69% | 9.84% | -3.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.10% | -50.14% | -16.34% | 11.90% | -9.24% |
| Change in Net Operating Assets | -519.88% | -173.97% | 46.01% | -203.57% | -74.61% |
| Cash from Operations | -36.35% | -53.63% | -64.65% | -62.26% | -167.80% |
| Capital Expenditure | -- | 96.67% | 100.00% | 83.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 96.67% | 100.00% | 83.33% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.71% | -8.94% | 13.95% | 13.81% | 14.01% |
| Issuance of Common Stock | -88.11% | 392.93% | 142.45% | -97.18% | 6,131.98% |
| Repurchase of Common Stock | 56.60% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.19% | 366.63% | 11,066.67% | -106.59% | 120,030.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -280.69% | 198.39% | -54.51% | -278.89% | 272.57% |